8-week Sofosbuvir-velpatasvir-voxilaprevir Less Effective for HCV 8-week Sofosbuvir-velpatasvir-voxilaprevir Less Effective for HCV

For patients with chronic hepatitis C virus (HCV) infection, eight weeks of combined sofosbuvir-velpatasvir-voxilaprevir may not be as effective as 12 weeks of only sofosbuvir-velpatasvir, results from two phase 3 open-label trials suggest.Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Gastroenterology News Source Type: news